Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression.

Sneed JR, Culang ME, Keilp JG, Rutherford BR, Devanand DP, Roose SP.

Am J Geriatr Psychiatry. 2010 Feb;18(2):128-35. doi: 10.1097/JGP.0b013e3181c796d2.

2.

Change in cognitive functioning following acute antidepressant treatment in late-life depression.

Culang ME, Sneed JR, Keilp JG, Rutherford BR, Pelton GH, Devanand DP, Roose SP.

Am J Geriatr Psychiatry. 2009 Oct;17(10):881-8.

3.

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

Burke WJ, Gergel I, Bose A.

J Clin Psychiatry. 2002 Apr;63(4):331-6.

PMID:
12000207
4.

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.

Feighner JP, Overø K.

J Clin Psychiatry. 1999 Dec;60(12):824-30.

PMID:
10665628
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
6.
7.

Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?

Barak Y, Kimhi R, Weizman R.

Int Clin Psychopharmacol. 2000 Jan;15(1):53-6.

PMID:
10836288
8.

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.

Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H; Old-Old Depression Study Group.

Am J Psychiatry. 2004 Nov;161(11):2050-9.

PMID:
15514406
9.
10.

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.

Curr Med Res Opin. 2007 Feb;23(2):401-16.

PMID:
17288694
11.
12.

Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.

Näslund J, Hieronymus F, Emilsson JF, Lisinski A, Nilsson S, Eriksson E.

Acta Psychiatr Scand. 2017 Oct;136(4):343-351. doi: 10.1111/acps.12784. Epub 2017 Aug 31.

PMID:
28859218
13.

Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M.

Eur J Pain. 2005 Feb;9(1):33-8.

PMID:
15629872
14.
15.
16.

Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.

Kasckow J, Lanouette N, Patterson T, Fellows I, Golshan S, Solorzano E, Zisook S.

Int J Geriatr Psychiatry. 2010 Feb;25(2):183-90. doi: 10.1002/gps.2318.

17.

Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.

Alexopoulos GS, Manning K, Kanellopoulos D, McGovern A, Seirup JK, Banerjee S, Gunning F.

Psychol Med. 2015 Oct;45(14):3111-20. doi: 10.1017/S0033291715001075. Epub 2015 Jul 14.

18.

Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.

Rocca P, Calvarese P, Faggiano F, Marchiaro L, Mathis F, Rivoira E, Taricco B, Bogetto F.

J Clin Psychiatry. 2005 Mar;66(3):360-9.

PMID:
15766303
19.

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.

Lepola UM, Loft H, Reines EH.

Int Clin Psychopharmacol. 2003 Jul;18(4):211-7.

PMID:
12817155
20.

An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.

Markowitz JS, DeVane CL, Liston HL, Montgomery SA.

Int Clin Psychopharmacol. 2000 Nov;15(6):329-33.

PMID:
11110008

Supplemental Content

Support Center